#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12636	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2242	560.2	0	.	n	.	0	A662G	SNP	662	662	A	970	970	G	677	G	635	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12636	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2242	560.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1758	1758	T	751	T,C	695,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12636	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2242	560.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1492	1492	C	761	C,A	716,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12636	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2242	560.2	0	HET	.	.	.	C757T	.	757	757	C	1065	1065	C	686	C,T	475,173	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23450	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3530	661.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1641	1641	A	777	A,G	734,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23450	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3530	661.6	0	.	n	.	0	C1346T	SNP	1346	1346	C	1650	1650	T	765	T,C	717,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23450	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3530	661.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2275	2275	C	725	C	696	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23450	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3530	661.6	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2901	2901	T	704	T,C	668,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23450	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3530	661.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2349	2349	A	753	A,T	724,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1802	folP	852	852	99.88	folP.l15.c30.ctg.1	1644	109.2	0	.	p	.	0	A204V	NONSYN	610	612	GCA	979	981	GTA	173;174;172	G;T;A	158;160;160	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1802	folP	852	852	99.88	folP.l15.c30.ctg.1	1644	109.2	1	SNP	p	R228S	0	.	.	682	684	CGC	1051	1053	CGC	170;170;171	C;G;C	162;163;163	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4574	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3432	133.0	1	SNP	p	S91F	0	.	.	271	273	TCC	634	636	TCC	148;148;149	T;C;C,A	137;139;137,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4574	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3432	133.0	1	SNP	p	D95N	0	.	.	283	285	GAC	646	648	GAC	154;154;153	G;A;C	147;146;145	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4574	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3432	133.0	1	SNP	p	D95G	0	.	.	283	285	GAC	646	648	GAC	154;154;153	G;A;C	147;146;145	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	531	1474	mtrR	633	633	99.68	mtrR.l6.c30.ctg.1	1385	106.0	0	.	p	.	0	N71fs	FSHIFT	211	211	A	540	540	A	183	A	174	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	776	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	1123	68.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4298	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2989	143.5	0	.	p	.	0	G459S	NONSYN	1375	1377	GGT	1761	1763	AGT	214;215;214	A;G;T	196;197;193	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4298	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2989	143.5	1	SNP	p	D86N	0	.	.	256	258	GAC	642	644	GAC	156;157;159	G;A;C	149;144;155	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4298	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2989	143.5	1	SNP	p	S87R	0	.	.	259	261	AGT	645	647	AGT	159;158;160	A;G;T	151;153;152	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4298	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2989	143.5	1	SNP	p	S87W	0	.	.	259	261	AGT	645	647	AGT	159;158;160	A;G;T	151;153;152	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4298	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2989	143.5	1	SNP	p	S87I	0	.	.	259	261	AGT	645	647	AGT	159;158;160	A;G;T	151;153;152	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4298	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2989	143.5	1	SNP	p	S88P	0	.	.	262	264	TCC	648	650	TCC	164;166;165	T;C;C	154;158;156	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3936	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2506	156.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1475	1477	GGC	203;200;201	G;G;C	191;185;186	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2330	155.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1239	1241	GCA	180;181;182	G;C;A	164;166;168	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2330	155.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1242	1244	ATC	185;185;187	A;T;C	170;171;173	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2330	155.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1254	1256	GTG	185;184;188	G;T;G	172;168;174	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2330	155.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1254	1256	GTG	185;184;188	G;T;G	172;168;174	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2330	155.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1758	1760	ACC	172;172;173	A;C;C	154;157;159	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2330	155.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1812	1814	GCG	183;183;184	G;C;G	164;144;151	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2330	155.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1812	1814	GCG	183;183;184	G;C;G	164;144;151	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2330	155.1	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1935	1937	GGT	184;185;186	G;G;T	172;172;170	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2330	155.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1944	1946	GGC	187;187;185	G;G;C	169;171;168	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2330	155.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1962	1964	CCG	188;187;188	C,G;C;G	136,1;159;142	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5168	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3178	162.2	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1727	1729	CTG	183;184;183	C;T;G	173;173;171	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1994	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1965	101.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	488	490	GGC	132;135;136	G;G;C	122;122;122	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1994	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1965	101.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	670	670	C	140	C	131	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	E48G	NONSYN	142	144	GAA	349	351	GGA	203;203;205	G;G;A	193;189;194	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	V75I	NONSYN	223	225	GTT	430	432	ATT	202;204;205	A;T;T	190;191;193	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	T89S	NONSYN	265	267	ACC	472	474	AGC	207;207;208	A;G;C	200;200;200	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	V98I	NONSYN	292	294	GTC	499	501	ATC	209;208;203	A;T;C	196;196;191	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	.	MULTIPLE	358	359	AA	564	565	CG	203;204	C;G,A	192;187,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	.	MULTIPLE	361	362	GA	567	569	CAG	205;202;197	C,G;A;G,A	194,1;193;187,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	N122K	NONSYN	364	366	AAC	571	573	AAA	198;196;197	A;A;A,C	192;189;193,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	598	600	TAT	214;212;210	T;A,T;T	204;202,1;198	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	N134E	NONSYN	400	402	AAT	607	609	GAG	203;203;200	G,A;A;G,T	185,1;189;186,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	V135L	NONSYN	403	405	GTG	610	612	CTT	199;200;201	C,G;T;T,G	186,1;186;185,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	G140K	NONSYN	418	420	GGA	625	627	AAA	194;195;195	A,G;A,G;A	182,1;182,1;183	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	K143E	NONSYN	427	429	AAA	634	636	GAA	202;204;203	G,C;A;A	190,1;192;189	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	V151A	NONSYN	451	453	GTA	658	660	GCA	222;223;224	G;C;A	201;204;205	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	T213S	NONSYN	637	639	ACA	844	846	TCA	206;207;209	T,G;C;A	192,1;191;194	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	964	966	CAA	156;153;152	C;A;A	146;146;144	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	.	INDELS	760	762	ACA	968	972	ATCAA	146;147;148;148;148	A,G;T;C;A;A	138,1;141;140;142;142	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	.	INDELS	763	764	TG	975	977	AGT	145;146;145	A;G;T	139;137;140	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	A257D	NONSYN	769	771	GCT	982	984	GAT	141;140;142	G;A;T	137;134;136	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1090	1092	AGT	243;243;246	A;G;T	216;218;219	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1096	1098	GAC	249;250;249	G;A;C	222;224;224	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1099	1101	TAC	247;245;243	T;A;C	223;221;220	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	0	.	p	.	0	S335A	NONSYN	1003	1005	TCG	1216	1218	GCG	160;157;155	G;C;G	152;149;146	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	1	SNP	p	G120K	1	.	.	358	360	AAG	564	566	CGG	203;204;202	C;G,A;G,A	192;187,1;189,1	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	1	SNP	p	D121N	0	.	.	361	363	GAC	567	570	CGC	205;197;196	C,G;G,A;C	194,1;187,1;189	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2448	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1393	173.7	1	SNP	p	A121D	1	.	.	361	363	GAC	567	570	CGC	205;197;196	C,G;G,A;C	194,1;187,1;189	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9734	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	4845	200.2	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2047	2049	CAT	207;206;205	C,A;A;T	194,1;193;193	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1066	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1091	97.3	1	SNP	p	V57M	1	.	.	169	171	ATG	594	596	ATG	215;216;213	A;T;G	200;198;199	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
